JOSEPH K SCHACHLE
CIK 1145914 · Chief Operating Officer · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
24
Lifetime Open-Market Net
-$39.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Chief Operating Officer | 296,084 | $1.17 | $346.4K | -$39.9K | 6 | 2026-04-27 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | EVP, Pulmonary Business | 20,000 | — | — | $0 | 18 | 2011-05-16 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-11-14 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-17 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-17 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-23 | INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.